Download FREE Report Sample
Download Free samplePoractant Alfa is a natural extract, phospholipids account for 90% of the dry weight, most of which are phosphatidyl choline (PC), the PC with surface activity is phosphatidyl choline dipalmitic acid, the rest of the phospholipids also include phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol and sphingomyelin.In addition, there are two kinds of sp-b and sp-c, which show the active substance (PS) specific proteins.Porcine pneumophylline injection for the treatment and prevention of respiratory distress syndrome (RDS) in premature infants.
Poractant Alfa Market contains market size and forecasts of Poractant Alfa in global, including the following market information:
Global Poractant Alfa Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Poractant Alfa Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Poractant Alfa companies in 2021 (%)
The global Poractant Alfa market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rapid Dosing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Poractant Alfa include Chiesi, Douglas Pharma, Takeda, Mylan and Piramal, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Poractant Alfa manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poractant Alfa Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Poractant Alfa Market Segment Percentages, by Type, 2021 (%)
Rapid Dosing
Microdosing
Global Poractant Alfa Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Poractant Alfa Market Segment Percentages, by Application, 2021 (%)
Salvage Treatment
Prevention of Respiratory Distress Syndrome (RDS)
Global Poractant Alfa Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Poractant Alfa Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Poractant Alfa revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Poractant Alfa revenues share in global market, 2021 (%)
Key companies Poractant Alfa sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Poractant Alfa sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chiesi
Douglas Pharma
Takeda
Mylan
Piramal
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
